Brief Reports
Copyright ©The Author(s) 2001.
World J Gastroenterol. Feb 15, 2001; 7(1): 83-87
Published online Feb 15, 2001. doi: 10.3748/wjg.v7.i1.83
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 The effects of VES on total TGF-β1 in SGC-7901 cells.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 The effects of VES on the expression of active TGF-β1 in SGC-7901 cells.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 The expression of c-Jun in VES treated SGC-7901 cells at 10 mg/L for different time. A. Protein marker; B. VES treatment for 0 h; C. VES treatment for 3 h; D. VES treatment for 6 h; E. VES-treatment for 12 h; F. VES treatment for 24 h; G. VES- treatment for 48 h.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 The expression of c-Jun in VES-treated SGC-7901 cells. (a) VES-treated SGC-7901 cells for 24 h; (b) VES-treated SGC-7901 cells for 48 h. A. Protein marker; B. Control; C. VES at 5 mg/L; D. VES at 10 mg/L; E. VES at 20 mg/L.
Figure 5
Open in New Tab Full Size Figure Download Figure
Figure 5 The expression of JNK1 in VES-treated SGC-7901 cells at 10 mg/L for different time points. A. Protein marker; B. VES- treatment for 0 h; C. VES treatment for 3 h; D. VES treatment for 6 h; E. VES treatment for 12 h; F. VES treatment for 24 h; G. VES treatment for 48 h.
Figure 6
Open in New Tab Full Size Figure Download Figure
Figure 6 The expression of JNK1 in VES-treated SGC-7901 cells. (a) VES-treated SGC-7901 cells for 24 h; (b) VES-treated SGC-7901 cells for 48 h. A. Protein marker; B. Control; C. VES at 5 mg/L; D. VES at 10 mg/L; E. VES at 20 mg/L.